STT Preferred Yield Fails to Shift Fair-Value Stance

What happened

State Street's Q2 results highlighted in the article show a 70% YoY EPS jump and a 20%+ AUM surge, boosting full-year guidance and reaffirming midterm targets of mid-20% ROTCE and 2028-2029 EPS of $16.5-$17. However, the master report notes this momentum is already partially priced in after a 27.5% 12-month rally to $128.50, or 12.2x earnings and 1.3x book, with structural fee compression and high uninsured deposits capping upside. The article's emphasis on the 6.8% preferred yield suggests income appeal, but common-equity investors face a balanced risk/reward at current levels. Actual quarterly data show Q3 2025 EPS of $2.83 and ROE 13.4%, supporting improved profitability but not the 70% EPS growth claimed relative to recent quarters. The discrepancy warrants caution about overly promotional coverage.

Implication

For investors, the article’s highlight of a 6.8% preferred yield may attract income seekers, but common stockholders should focus on whether management can deliver the projected EPS of $16.5-$17 by 2028-2029, which implies a forward P/E of roughly 7.5-7.8x at current price—not demanding but reliant on mid-20% ROTCE execution. The master report already accounts for strong 3Q25 results, and further price appreciation likely requires positive regulatory outcomes, successful mandate conversions, and stable deposit behavior. The 70% EPS growth figure cited is not consistent with recent reported quarterly data (Q2 2025 EPS of $2.20 vs. $2.18 a year earlier), suggesting the article may be using selective or forward-looking metrics. Given the stock’s 27.5% run over the past year and structural headwinds, risk/reward remains balanced, favoring patience over aggressive accumulation. Watch for upside catalysts like sustained ROE above 13% and >$3.6T mandate pipeline installs, or downside from Basel III capital burdens or client attrition.

Thesis delta

No material change to the existing WAIT thesis. The article reinforces positive operating momentum and management's long-term targets, but these were already incorporated in prior analysis. The preferred yield angle does not address the common-equity valuation concerns regarding fee compression, uninsured deposits, and regulatory costs.